Abstract
Evaluation for psychiatric and cognitive dysfunction is a crucial part of preoperative assessment for deep brain stimulation (DBS) surgery. All candidates for DBS should be treated for active psychiatric disorders, and the treatment team should also screen for past psychiatric history, which may predispose to postoperative psychiatric illness. A wide range of behavioral symptoms have been seen following DBS, including depression, hallucinations or true psychosis, mania, and impulsivity. Suicidal ideation should be treated aggressively. Cognitive changes may occur, but data are currently too limited to make predictions regarding subtle effects on cognition. However, patients with dementia may experience further decline in cognitive function following DBS.
Similar content being viewed by others
References and Recommended Reading
Aarsland D, Larsen JP, Lim NG, et al.: Range of neuropsychiatric disturbances in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999, 67:492–496.
Marder K, Jacobs DM: Dementia. In Parkinson’s Disease: Diagnosis and Clinical Management. Edited by Factor SA, Weiner JW. New York: Demos; 2001:125–135.
Mega MS, Cummings JL: Frontal-subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci 1994, 6:358–370.
Loher TJ, Burgunder JM, Pohle T, et al.: Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg 2002, 96:844–853.
Martinez-Martin P, Valldeoriola F, Tolosa E, et al.: Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson’s disease. Mov Disord 2002, 17:372–377.
Scott B, Borgman A, Engler H, et al.: Gender differences in Parkinson’s disease symptom profile. Acta Neurol Scand 2000, 102:37–43.
Schrag A, Jahanshahi M, Quinn NP: What contributes to depression in Parkinson’s disease? Psychol Med 2001, 31:65–73.
Berney A, Vingerhoets F, Perrin A, et al.: Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology 2002, 59:1427–1429.Although a third of those who developed depression had a prior history of affective disorder, other patients with a history of mood disorder did not develop postoperative depression. Half of the patients who developed depression were transiently suicidal; all required treatment. These results suggest that mood symptoms seen postoperatively should be treated aggressively.
Doshi PK, Chhaya N, Bhatt MH: Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson’s disease. Mov Disord 2002, 17:1084–1085.
Houeto JL, Mesnage V, Mallet L, et al.: Behavioural disorders, Parkinson’s disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:701–707.In this series of 24 deep brain stimulation cases, anxiety symptoms were seen in 75% of patients postoperatively. They also found that many patients developed generalized anxiety disorder, but also had particular concerns about sudden stimulator failure. Depression developed in five patients, four of whom had prior history of depressive symptoms. However, other patients with past history of depression did not develop mood symptoms postoperatively, making risk for depression difficult to predict.
Thobois S, Mertens P, Guenot M, et al.: Subthalamic nucleus stimulation in Parkinson’s disease: clinical evaluation of 18 patients. J Neurol 2002, 249:529–534.
Bejjani BP, Damier P, Arnulf I, et al.: Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999, 340:1476–1480.
Moro E, Scerrati M, Romito LM, et al.: Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 1999, 53:85–90.
Woods SP, Fields JA, Lyons KE, et al.: Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson’s disease: a one-year followup. Acta Neurochir (Wien) 2001, 143:1273–1277.
Ardouin C, Pillon B, Peiffer E, et al.: Bilateral subthalamic or pallidal stimulation for Parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999, 46:217–223.
Burchiel KJ, Anderson VC, Favre J, Hammerstad JP: Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson’s disease: results of a randomized, blinded pilot study. Neurosurgery 1999, 45:1375–1382.
Groenewegen HJ, Berendse HW: Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol 1990, 294:607–622.
Rodriguez-Oroz MC, Rodriguez M, Curidi J, et al.: The subthalamic nucleus in Parkinson’s disease: somatotopic organization and physiological characteristics. Brain 2001, 124:1777–1790.
Ceballos-Baumann AO, Boecker H, Bartenstein P, et al.: A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 1999, 56:997–1003.
Potter WZ, Rudorfer MV, Manji H: The pharmacologic treatment of depression. N Engl J Med 1991, 325:633–642.
Dinsky IA, Jouandet ML, Goldman-Rakic PS: Organization of the nigrothalamocortical system in the rhesus monkey. J Comp Neurol 1985, 236:315–330.
Goldman-Rakic PS, Porrino LJ: The primate mediodorsal (MD) nucleus and its projection to the frontal lobe. J Comp Neurol 1985, 242:535–560.
Giovannoni G, O’Sullivan JD, Turner K, et al.: Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000, 68:423–428.
Kulisevsky J, Berthier ML, Gironell A, et al.: Mania following deep brain stimulation for Parkinson’s disease. Neurology 2002, 59:1421–1424.
Miyawaki E, Perlmutter JS, Troster AI, et al.: The behavioral complications of pallidal stimulation: a case report. Brain Cogn 2000, 42:417–434.
Kumar K, Kelly M, Toth C: Deep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson’s disease and essential tremor. Stereotact Funct Neurosurg 1999, 72:47–61.
Richard IH, Schiffer RB, Kurlan R: Anxiety and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 1996, 8:383–392.
Alegret M, Junque C, Valldeoriola F, et al.: Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease. Arch Neurol 2001, 58:1223–1227.Pre- and postoperative neuropsychologic evaluation of 15 patients who underwent implantation for subthalamic nucleus deep brain stimulation (STN-DBS). Although some deterioration was seen in verbal memory, executive, and visuospatial functions on formal testing, the authors concluded that STN-DBS improved motor symptoms in Parkinson’s disease without clinically relevant neuropsychologic decline.
Diederich NJ, Alesch F, Goetz CG: Visual hallucinations induced by deep brain stimulation in Parkinson’s disease. Clin Neuropharmacol 2000, 23:287–289.
Iranzo A, Valldeoriola F, Santamaria J, et al.: Sleep symptoms and polysomnographic architecture in advanced Parkinson’s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:661–664.Studied changes in sleep quality in 11 Parkinson’s disease patients following deep brain stimulation surgery. Sleep quality improved subjectively in the majority of patients. Polysomnographic studies also demonstrated an increase in uninterrupted sleep and a decrease in the arousal index. Benefits of this procedure on sleep were attributed to positive effects on nocturnal mobility and decrease of sleep fragmentation.
Shulman LM, Taback RL, Bean J, Weiner WJ: Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 2001, 16:507–510.
Foncke E, van der LC, Vandewalle V, et al.: Chronic bilateral stimulation of the subthalamic nucleus (STN) in 15 patients with advanced ideopathic Parkinson’s disease previously treated with unilateral internal globus pallidus (GPi) stimulation. Neurology 2001, 56(suppl 3):A272.
Hariz MI, Johansson F, Shamsgovara P: Bilateral subthalamic nucleus stimulation in a Parkinsonian patient with preoperative deficits in speech and cognition: persisting improvement in mobility but increased dependency. A case study. Mov Disord 2000, 15:136–139.
Limousin P, Krack P, Pollak P, et al.: Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998, 339:1105–1111.
Saint-Cyr JA, Trepanier LL, Kumar R, et al.: Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 2000, 123)(Pt 10):2091–2108. Before and after study of 11 Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Mild cognitive declines were found 12 months later in working memory, speed of mental processing, encoding of visuospatial material, phonemic fluency, long-term consolidation of verbal material, and set switching. Patients older than 69 years of age showed more consistent declines. These results suggest that older patients should receive careful evaluation for memory deficits prior to surgery, because they are at greater risk of postoperative cognitive compromise.
Fields JA, Troster AI: Cognitive outcomes after deep brain stimulation for Parkinson’s disease: a review of initial studies and recommendations for future research. Brain Cogn 2000, 42:268–293.
Lezak MD: Neuropsychological Assessment, edn 3. Oxford: Oxford University Press; 1995.
Jahanshahi M, Ardouin CM, Brown RG, et al.: The impact of deep brain stimulation on executive function in Parkinson’s disease. Brain 2000, 123(Pt 6):1142–1154.
Perozzo P, Rizzone M, Bergamasco B, et al.: Deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: comparison of pre- and postoperative neuropsychological evaluation. J Neurol Sci 2001, 192:9–15.
Pillon B, Ardouin C, Damier P, et al.: Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson’s disease. Neurology 2000, 55:411–418.Before and after study of 62 Parkinson’s disease patients with either subthalamic nucleus or globus pallidum internus deep brain stimulation (DBS). The authors found that DBS did not significantly affect the patients’ cognitive performance 12 months after surgery other than a mild but significant deficit in lexical fluency.
Trepanier LL, Kumar R, Lozano AM, et al.: Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson’s disease. Brain Cogn 2000, 42:324–347.
Van Horn G, Schiess MC, Soukup VM: Subthalamic deep brain stimulation: neurobehavioral concerns. Arch Neurol 2001, 58:1205–1206.
Molinuevo JL, Valldeoriola F, Tolosa E, et al.: Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease. Arch Neurol 2000, 57:983–988.
Volkmann J, Allert N, Voges J, et al.: Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 2001, 56:548–551.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anderson, K.E., Mullins, J. Behavioral changes associated with deep brain stimulation surgery for Parkinson’s disease. Curr Neurol Neurosci Rep 3, 306–313 (2003). https://doi.org/10.1007/s11910-003-0007-z
Issue Date:
DOI: https://doi.org/10.1007/s11910-003-0007-z